Urinary Incontinence Treatment Devices Market (Product: Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Catheters) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Urinary Incontinence Treatment Devices market size was valued at USD 2.11 billion in 2021 and is predicted to hit USD 5.20 billion by 2030 with a registered CAGR of 7.9% during the forecast period 2022 to 2030.

Urinary incontinence is defined as involuntary release of urine due to loss of bladder control. Urinary incontinence devices are used for the treatment of urinary incontinence. Over 500 million people across the globe are affected by the condition and its incidence increases with age. Several factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence symptoms.

The global urinary incontinence treatment devices market size is likely to grow at a rapid pace during the forecast period. High prevalence of urinary incontinence and overactive bladder across the globe and technological advancements, such as non-implantable electrical stimulation devices, are projected to propel the global market during the forecast period.

Report Scope of the Urinary Incontinence Treatment Devices Market

High Prevalence of Urinary Incontinence and Overactive Bladder to Drive Global Market

Urinary incontinence is one of the highly prevalent and largely underreported and under diagnosed urological disorders in the world, affecting millions of people. It has a severe effect on physical, psychological, and emotional health of patients. Women are affected twice as much as men, and the incidence increases with age. Several factors such as weak pelvic floor muscles, urethral sphincters, obesity, pregnancy & childbirth, urinary tract infection, and neurological disorders cause urinary incontinence. Around 200 million people are affected by some form of urinary incontinence or bladder problems. Urinary incontinence and stress urinary incontinence are the most common forms affecting millions of people globally. Therefore, a large patient pool with stress urinary incontinence and overactive bladder symptoms is expected to augment the global urinary incontinence treatment devices market during the forecast period.

Increase in Incidence of Prostate Cancer Fueling Global Market

Patients undergoing radical prostectomy surgery are at a high risk of developing post prostatectomy urinary incontinence. Radical prostectomy surgery, either through radiation or surgical dissection, affects the bladder’s capacity to hold urine or causes spasms that force urine out. Additionally, radical prostectomy surgery adversely affects the nerves that control bladder function, resulting in urinary incontinence. Prostate cancer is the fourth-leading cancer affecting both men and women, and it is the second most common cancer in men followed by lung cancer. Studies have shown that the rate of stress urinary incontinence among men ranges from 2% to 69% after undergoing prostate surgery. This factor is likely to drive the global urinary incontinence treatment devices market during the forecast period.

High Success Rate Bolstering Electrical Stimulation Devices Segment

In terms of product, the global urinary incontinence treatment devices market has been classified into urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters. The urethral slings segment has been bifurcated into female slings and male slings. The electrical stimulation devices segment has been spilt into implantable and non-implantable.

The electrical stimulation devices segment dominated the global urinary incontinence treatment devices market, with a share of around 42% in 2021. The trend is expected to continue during the forecast period. The electrical stimulation devices segment is propelled by rise in the demand for minimally invasive/wearable and non-implantable electrical stimulation devices to strengthen the pelvic floor muscles, high success rates with electrical stimulation devices, and favorable medical reimbursement policies in developed countries for implantable electrical stimulation devices.

Higher Cost of Treatment Devices Driving Urge Urinary Incontinence Segment

Based on incontinence type, the global urinary incontinence treatment devices market has been segregated into stress urinary incontinence, urge urinary incontinence, mixed incontinence, and overflow incontinence. The urge incontinence segment held major share of around 40% of the global market in 2021. The trend is likely to continue during the forecast period. Growth of the segment can be attributed to higher cost of treatment devices, especially implantable electrical stimulation devices, than other treatment devices/methods such as indwelling Foley catheters. Furthermore, analysis of global urinary incontinence treatment devices market trends revealed an increase in incidence of urge incontinence, rise in adoption of electrical stimulation devices for overactive bladder treatment, and new product launches are likely to propel the segment during the forecast period.

Favorable Reimbursement Policies for Medical Devices Augmenting Hospitals Segment

In terms of end-user, the global urinary incontinence treatment devices market has been divided into hospitals, ambulatory surgery centers, clinics, and home use. The hospitals segment held major share of around 60% of the global market in 2021. Growth of the segment can be attributed to increase in the number of surgical procedures for the treatment of all types of urinary incontinence and favorable reimbursement policies for medical devices in most of the developed and developing countries.

Regional Outlook of Global Urinary Incontinence Treatment Devices Market

North America accounted for the largest global urinary incontinence treatment devices market share of around 42.9% in 2021. Early adoption of technologies, large patient pool of urinary incontinence, and easy availability & lucrative medical reimbursement policies in the U.S. and Canada are attributed to North America’s prominent market share in 2021.

Europe held around 32.8% share of the global market in 2021. The market in the region grew at a faster growth rate in 2021 owing to high prevalence and increase in incidence of urinary incontinence, surge in adoption of technologically advanced products, large base of medical device companies, and high number of products in pipeline for the treatment of urinary incontinence.

Asia Pacific held larger share of the global urinary incontinence treatment devices market than Latin America and Middle East & Africa. However, the market in Latin America is likely to grow at a faster pace than in Middle East & Africa.

Key Developments in Global Urinary Incontinence Treatment Devices Market

• In December 2021, Caldera Medical had received FDA clearance for DESARA TVez, a device to treat female stress urinary incontinence
• In May 2020, Rigicon had announced the launch of two new artificial urinary sphincter systems for incontinence treatment. The two devices launched were ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter. These devices are used as implants to treat urinary incontinence.

Some of the prominent players in the Urinary Incontinence Treatment Devices Market include:

• C. R. Bard, Inc. (Becton, Dickinson and Company)
• Coloplast Group
• Promedon Group
• A.M.I. GmbH
• Ethicon US, LLC. (Johnson & Johnson)
• ZSI Surgical Implants S.R.L.
• Medtronic plc
• InControl Medical LLC
• Hollister Incorporated
• Atlantic Therapeutics Group Ltd.
• B. Braun Melsungen AG
• Teleflex Incorporated

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Urinary Incontinence Treatment Devices market

• Product
• Urethral Slings
• Female Slings
• Male Slings
• Electrical Stimulation Devices
• Implantable
• Non-implantable
• Artificial Urinary Sphincters
• Catheters
• Incontinence Type
• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Mixed Incontinence
• Overflow Incontinence
• End-user
• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Home Use

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Urinary Incontinence Treatment Devices industry analysis from 2022 to 2030 to identify the prevailing Urinary Incontinence Treatment Devices industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Urinary Incontinence Treatment Devices industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Urinary Incontinence Treatment Devices industry trends, key players, market segments, application areas, and market growth strategies.